LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND UP TO 6.9-YEARS OF TREATMENT

被引：0
|
作者：
Caporali, Roberto [1 ]
Aletaha, Daniel [2 ]
Sanmarti, Raimon [3 ,4 ]
Takeuchi, Tsutomu [5 ]
Mo, Daojun [6 ]
Haladyj, Ewa [6 ]
Zaremba-Pechmann, Liliana [7 ]
Taylor, Peter C. [8 ]
Pile, Kevin [9 ]
机构：
[1] Univ Milan, Dept Clin Sci & Community Hlth, Res Ctr Adult & Pediat Rheumat Dis, Milan, Italy
[2] Med Univ Vienna, Div Rheumatol, Dept Med 3, Vienna, Austria
[3] Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain
[4] IDIBAPS, Barcelona, Spain
[5] Keio Univ, Div Rheumatol, Dept Internal Med, Sch Med, Tokyo, Japan
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] HaaPACS GmbH, Schriesheim, Germany
[8] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Botnar Res Ctr, Oxford, England
[9] Western Sydney Univ, Sydney, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ARA-P64
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [1] Long-Term Efficacy of Baricitinib in Patients with Rheumatoid Arthritis with Inadequate Response to Bdmards: Results from RA-BEYOND up to 6.9-Years of Treatment
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 517 - 518
  • [2] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND UP TO 6.9-YEARS OF TREATMENT
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    [J]. RHEUMATOLOGY, 2023, 62
  • [3] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH INADEQUATE RESPONSE TO BDMARDS: RESULTS FROM RA-BEYOND FOLLOWING 6.9 YEARS OF TREATMENT
    Caporali, R.
    Aletaha, D.
    Sanmarti, R.
    Takeuchi, T.
    Mo, D.
    Haladyj, E.
    Zaremba-Pechmann, L.
    Taylor, P. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 617 - 618
  • [4] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CSDMARDS: RESULTS FROM RA-BEYOND UP TO 7 YEARS OF TREATMENT
    Caporali, R.
    Aletaha, D.
    Sanmarti, R.
    Takeuchi, T.
    Mo, D.
    Haladyj, E.
    Zaremba-Pechmann, L.
    Taylor, P. C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 630 - 631
  • [5] LONG-TERM EFFICACY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO HAVE HAD INADEQUATE RESPONSE TO CSDMARDS: RESULTS FROM RA-BEYOND UP TO 7 YEARS OF TREATMENT
    Caporali, Roberto
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Zaremba-Pechmann, Liliana
    Taylor, Peter C.
    [J]. RHEUMATOLOGY, 2023, 62
  • [6] Radiographic Progression of Structural Joint Damage over 5 Years of Baricitinib Treatment in Patients with Rheumatoid Arthritis: Results from RA-BEYOND
    van der Heijde, Desiree
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND
    van der Heijde, Desiree
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas
    Mo, Daojun
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    [J]. JOURNAL OF RHEUMATOLOGY, 2022, 49 (02) : 133 - 141
  • [8] RADIOGRAPHIC PROGRESSION OF STRUCTURAL JOINT DAMAGE OVER 5 YEARS OF BARICITINIB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM RA-BEYOND
    Van der Heijde, Desiree
    Kartman, Cynthia E.
    Xie, Li
    Beattie, Scott
    Schlichting, Douglas
    Durez, Patrick
    Tanaka, Yoshiya
    Fleischmann, Roy
    Imbert, Denisse
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 : S111 - S111
  • [9] Radiographic progression of structural joint damage over five years of baricitinib treatment in patients with rheumatoid arthritis: results from RA-BEYOND
    van der Heijde, D.
    Kartman, C. E.
    Xie, L.
    Beattie, S.
    Schlichting, D.
    Durez, P.
    Tanaka, Y.
    Fleischmann, R.
    Hanssen-Bauer, A.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 27 - 27
  • [10] Efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis up to 6.5 years of treatment: results of a long-term study
    Caporali, Roberto
    Taylor, Peter C.
    Aletaha, Daniel
    Sanmarti, Raimon
    Takeuchi, Tsutomu
    Mo, Daojun
    Haladyj, Ewa
    Bello, Natalia
    Zaremba-Pechmann, Liliana
    Fang, Ying
    Dougados, Maxime
    [J]. RHEUMATOLOGY, 2024, 63 (10) : 2799 - 2809
12345